Vasculoprotective Effects of Combined Endothelial Progenitor Cells and Mesenchymal Stem Cells in Diabetic Wound Care: Their Potential Role in Decreasing Wound-Oxidative Stress

Table 1

The means ± SEM of the body weight and blood glucose on day 7 and 14 after wounding in the wound control group with implanted fibrin gel (control), diabetic wound group with implanted fibrin gel (DM), diabetic wound group with implanted fibrin gel and 1×10⁶ MSCs (DM + MSCs), diabetic wound group with implanted fibrin gel and 1×10⁶ EPCs (DM + EPCs), and diabetic wound group with implanted fibrin gel and combined 0.5×10⁶ EPCs and 0.5×10⁶ MSCs (DM + EPCs + MSCs).

Group	Body weight (g)		Blood glucose level (mg/dL)
	Day 7	Day 14	Day 7	Day 14
Control	25.91±1.22	26.06±1.45	115.17±14.28	120.40±11.52
DM	23.86±2.07	24.77±0.72	347.83±59.41 **	362.83±57.56 **
DM + MSCs	21.81±1.40	22.61±2.32	361.33±18.63 **	425.00±104.74 **
DM + EPCs	24.76±1.41	22.86±1.30	344.17±61.21 **	362.40±35.56 *
DM + EPCs + MSCs	24.57±1.07	23.60±0.71	312.33±15.05 **	376.50±82.19 *

^∗𝑃<0.05: significant difference compared to control group.
** 𝑃<0.01: significant difference compared to control group.